Israeli - Kiebrania - Ministry of Health

inovamed ltd - montelukast as sodium 5 mg - chewable tablets - montelukast - montelukast inovamed is indicated in pediatric patients 6 to 14 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.montelukast inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 6 to 14 years of age.

Israeli - Kiebrania - Ministry of Health

inovamed ltd - montelukast as sodium 4 mg - chewable tablets - montelukast - montelukast inovamed is indicated in pediatric patients 2 to 5 years of age for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. montelukast inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 to 5 years of age.

Israeli - Kiebrania - Ministry of Health

inovamed ltd - montelukast as sodium 10 mg - film coated tablets - montelukast - montelukast inovamed is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction.montelukast inovamed is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast inovamed and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast inovamed is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and adolescents 15 years of age and older.

Israeli - Kiebrania - Ministry of Health

inovamed ltd - eplerenone - טבליות מצופות פילם - eplerenone 25 mg - eplerenone

Israeli - Kiebrania - Ministry of Health

inovamed ltd - eplerenone - טבליות מצופות פילם - eplerenone 50 mg - eplerenone

Israeli - Kiebrania - Ministry of Health

taro international ltd, israel - dobutamine as hydrochloride - תמיסה לאינפוזיה - dobutamine as hydrochloride 250 mg / 20 ml - dobutamine

Israeli - Kiebrania - Ministry of Health

inovamed ltd - tamsulosin hydrochloride - טבליות בשחרור ממושך - tamsulosin hydrochloride 0.4 mg - tamsulosin

Israeli - Kiebrania - Ministry of Health

taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 30 mg - cinacalcet

Israeli - Kiebrania - Ministry of Health

taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 60 mg - cinacalcet

Israeli - Kiebrania - Ministry of Health

taro international ltd, israel - cinacalcet as hydrochloride - טבליות מצופות פילם - cinacalcet as hydrochloride 90 mg - cinacalcet